These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 728187)

  • 1. The effect of prolonged sodium phenobarbitone treatment on hepatic xenobiotic metabolism and the urinary excretion of metabolites of the D-glucuronic acid pathway in the rat.
    Lake BG; Longland RC; Harris RA; Severn BJ; Gangolli SD
    Biochem Pharmacol; 1978; 27(19):2357-61. PubMed ID: 728187
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic drug metabolism after phenobarbital and diphenylhydantoin administration in the rat--influence of vitamin D3 status.
    Gascon-Barré M; Côte MG; Brodeur J
    Biochem Pharmacol; 1979; 28(2):313-9. PubMed ID: 218591
    [No Abstract]   [Full Text] [Related]  

  • 3. Selenium antagonism of cadmium-induced inhibition of hepatic drug metabolism in the male rat.
    Early JL; Schnell RC
    Toxicol Appl Pharmacol; 1981 Mar; 58(1):57-66. PubMed ID: 7233439
    [No Abstract]   [Full Text] [Related]  

  • 4. Hexobarbital sleeping time and drug metabolism in rats with ligated bile ducts--a lack of correlation.
    Drew R; Priestly BG
    Biochem Pharmacol; 1976 Jul; 25(14):1659-63. PubMed ID: 942466
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug disposition in spontaneously hypertensive rats.
    Ben-Zvi Z; Kaplanski J; Warszawski D
    Pharmacol Res Commun; 1980 Oct; 12(9):873-6. PubMed ID: 7443767
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of pregnancy on the metabolism of drugs in the rat and rabbit.
    Neale MG; Parke DV
    Biochem Pharmacol; 1973 Jun; 22(12):1451-61. PubMed ID: 4738892
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term variation in basal and phenobarbital-stimulated oxidative drug metabolism in the rat.
    Beuthin PK; Bousquet WF
    Biochem Pharmacol; 1970 Feb; 19(2):620-5. PubMed ID: 5507672
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of n-hexane treatment on the glucuronic acid pathway and activity of some drug-metabolizing enzymes in guinea-pig.
    Notten WR; Henderson PT
    Biochem Pharmacol; 1975 Jan; 24(1):127-31. PubMed ID: 804901
    [No Abstract]   [Full Text] [Related]  

  • 9. Microsomal and parenchymal cell models in multiple drug metabolism.
    Lowery GL; Bidlack WR
    Proc West Pharmacol Soc; 1981; 24():141-5. PubMed ID: 7255437
    [No Abstract]   [Full Text] [Related]  

  • 10. The influence of some foreign compounds on hepatic xenobiotic metabolism and the urinary excretion of D-glucuronic acid metabolites in the rat.
    Lake BG; Longland RC; Gangolli SD; Lloyd AG
    Toxicol Appl Pharmacol; 1976 Jan; 35(1):113-22. PubMed ID: 1258048
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of treatment with some phase II substrates on hepatic xenobiotic metabolism and the urinary excretion of metabolites of the D-glucuronic acid pathway in the rat.
    Lake BG; Longland RC; Harris RA; Collins MA; Herod IA; Gangolli SD
    Toxicol Appl Pharmacol; 1980 Mar; 52(3):371-8. PubMed ID: 6768167
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of ibuprofen on drug-metabolizing enzymes in rat liver in vivo and in vitro.
    Reinicke C; Klinger W
    Biochem Pharmacol; 1975 Jan; 24(1):145-7. PubMed ID: 1122255
    [No Abstract]   [Full Text] [Related]  

  • 13. Monooxygenase reactions, glucuronic acid and sulphate conjugation in isolated hepatocytes.
    Bridges JW
    Toxicology; 1980; 18(3):195-204. PubMed ID: 7222051
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of parenteral dimethyl sulfoxide (DMSO) on drug metabolizing enzyme activities in the phenobarbital pretreated rat.
    Willson RA; Hart FE
    Biochem Pharmacol; 1977 May; 26(9):902-3. PubMed ID: 861058
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of levels of feed restriction on in vivo and in vitro alterations in drug metabolism and associated enzymes.
    Sachan DS; Su PK
    Drug Nutr Interact; 1986; 4(4):363-70. PubMed ID: 3792217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circadian rhythm in hexobarbital sleep time: a dose-response evaluation in the mouse.
    Holcslaw TL
    Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):49-60. PubMed ID: 725321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsomal drug metabolism during alpha-naphthylisothiocyanate-induced cholestasis.
    Drew R; Priestly BG
    Toxicol Appl Pharmacol; 1976 Mar; 35(3):491-9. PubMed ID: 1265763
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of dibromotetrafluoroethane inhalation on hepatic drug metabolism in mice.
    Murphy JP; Van Stee EW; Back KC
    Biochem Pharmacol; 1973 Nov; 22(22):2843-51. PubMed ID: 4761555
    [No Abstract]   [Full Text] [Related]  

  • 19. The excretion of metabolites of the D-glucuronic acid pathway in human urine. Effect of phenobarbitone administration.
    Lake BG; Longland RC; Harris RA; Gangolli SD; Rundle A
    Xenobiotica; 1982 Apr; 12(4):241-7. PubMed ID: 7113260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hexachlorophene, tribromsalan, trichlorcarban and cloflucarban on hexobarbital sleeping time and hepatic drug-metabolizing enzyme activity in vitro in the rat.
    Condie LW; Buhler DR
    Biochem Pharmacol; 1979; 28(3):375-80. PubMed ID: 426854
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.